Literature DB >> 21170927

Widely expressed Af17 is likely not required for embryogenesis, hematopoiesis, and animal survival.

Zhijing Zhang1, Le Huang, Mary Rose Reisenauer, Hongyu Wu, Lihe Chen, Yujin Zhang, Yang Xia, Wenzheng Zhang.   

Abstract

As a putative transcription factor, Af17 may play a role in multiple signaling pathways. However, the Af17 expression profile during development and in adult tissues remains largely uncharacterized. The importance of Af17 function in embryogenesis, hematopoiesis, and animal survival has never been addressed before. Here we report the generation of the first Af17 mutant mouse model and characterization of the Af17 temporal and spatial expression profile in various embryonic stages and adult tissues by X-gal staining, in situ hybridization, and RT-PCR. Af17 expression is detected in specific cell populations in all stages and in multiple tissues examined. In situ hybridization yielded a consistent Af17 expression pattern by X-gal staining. Homozygous mutant mice are viable, fertile, normal in size, and do not display any gross physical, behavioral, or hematopoietic abnormalities. Thus, our studies describe the generation of the first Af17 mutant mouse model, provide the first developmental profile of Af17 expression, and reveal that Af17 may be dispensable for normal embryogenesis, hematopoiesis, and animal survival.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21170927      PMCID: PMC3069500          DOI: 10.1002/dvg.20679

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  25 in total

1.  Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom).

Authors:  Man Mohan; Hans-Martin Herz; Yoh-Hei Takahashi; Chengqi Lin; Ka Chun Lai; Ying Zhang; Michael P Washburn; Laurence Florens; Ali Shilatifard
Journal:  Genes Dev       Date:  2010-03-04       Impact factor: 11.361

2.  AF17 competes with AF9 for binding to Dot1a to up-regulate transcription of epithelial Na+ channel alpha.

Authors:  Mary Rose Reisenauer; Marc Anderson; Le Huang; Zhijing Zhang; Qiaoling Zhou; Bruce C Kone; Andrew P Morris; Gene D Lesage; Stuart E Dryer; Wenzheng Zhang
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

3.  Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia.

Authors:  R Prasad; D Leshkowitz; Y Gu; H Alder; T Nakamura; H Saito; K Huebner; R Berger; C M Croce; E Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 4.  Molecular pathology of mixed-lineage leukemia.

Authors:  Christian Bach; Robert K Slany
Journal:  Future Oncol       Date:  2009-10       Impact factor: 3.404

Review 5.  PHD fingers: epigenetic effectors and potential drug targets.

Authors:  Catherine A Musselman; Tatiana G Kutateladze
Journal:  Mol Interv       Date:  2009-12

6.  A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia.

Authors:  T Chaplin; P Ayton; O A Bernard; V Saha; V Della Valle; J Hillion; A Gregorini; D Lillington; R Berger; B D Young
Journal:  Blood       Date:  1995-03-15       Impact factor: 22.113

7.  BR140, a novel zinc-finger protein with homology to the TAF250 subunit of TFIID.

Authors:  K A Thompson; B Wang; W S Argraves; F G Giancotti; D P Schranck; E Ruoslahti
Journal:  Biochem Biophys Res Commun       Date:  1994-02-15       Impact factor: 3.575

Review 8.  MLL fusions: pathways to leukemia.

Authors:  Han Liu; Emily H Y Cheng; James J D Hsieh
Journal:  Cancer Biol Ther       Date:  2009-07       Impact factor: 4.742

9.  Molecular characterisation of the Polycomblike gene of Drosophila melanogaster, a trans-acting negative regulator of homeotic gene expression.

Authors:  A Lonie; R D'Andrea; R Paro; R Saint
Journal:  Development       Date:  1994-09       Impact factor: 6.868

10.  NeuN, a neuronal specific nuclear protein in vertebrates.

Authors:  R J Mullen; C R Buck; A M Smith
Journal:  Development       Date:  1992-09       Impact factor: 6.868

View more
  7 in total

1.  Mineralocorticoid receptor antagonizes Dot1a-Af9 complex to increase αENaC transcription.

Authors:  Xi Zhang; Qiaoling Zhou; Lihe Chen; Stefan Berger; Hongyu Wu; Zhou Xiao; David Pearce; Xiaodong Zhou; Wenzheng Zhang
Journal:  Am J Physiol Renal Physiol       Date:  2013-09-11

Review 2.  Epigenetics and the control of the collecting duct epithelial sodium channel.

Authors:  Bruce C Kone
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

Review 3.  Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond.

Authors:  Chun-Wei Chen; Scott A Armstrong
Journal:  Exp Hematol       Date:  2015-06-25       Impact factor: 3.084

Review 4.  Epigenetics of epithelial Na(+) channel-dependent sodium uptake and blood pressure regulation.

Authors:  Wenzheng Zhang
Journal:  World J Nephrol       Date:  2015-07-06

5.  Af17 deficiency increases sodium excretion and decreases blood pressure.

Authors:  Lihe Chen; Hongyu Wu; Oleh M Pochynyuk; Mary Rose Reisenauer; Zhijing Zhang; Le Huang; Oleg Leonidovych Zaika; Mykola Mamenko; Weiru Zhang; Qiaoling Zhou; Mingyao Liu; Yang Xia; Wenzheng Zhang
Journal:  J Am Soc Nephrol       Date:  2011-05-05       Impact factor: 10.121

6.  Mllt10 knockout mouse model reveals critical role of Af10-dependent H3K79 methylation in midfacial development.

Authors:  Honami Ogoh; Kazutsune Yamagata; Tomomi Nakao; Lisa L Sandell; Ayaka Yamamoto; Aiko Yamashita; Naomi Tanga; Mai Suzuki; Takaya Abe; Issay Kitabayashi; Toshio Watanabe; Daisuke Sakai
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

7.  MLLT6 maintains PD-L1 expression and mediates tumor immune resistance.

Authors:  Sandeep Sreevalsan; Marietta Döring; Maciej Paszkowski-Rogacz; Melanie Brux; Carolina Blanck; Marten Meyer; Frank Momburg; Frank Buchholz; Mirko Theis
Journal:  EMBO Rep       Date:  2020-10-15       Impact factor: 9.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.